* Applied Molecular Transport Inc. AMTI.OQ AMTI.O is
expected
to show no change in quarterly revenue when it reports
results on May 8 (estimated).
*
* Refinitiv's mean analyst estimate for Applied Molecular
Transport Inc. is for a loss of 60 cents per share.
* The current average analyst rating on the shares is "sell"
and
the breakdown of recommendations is no "strong buy" or "buy," 2
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Applied
Molecular
Transport Inc. is $1.1, above its last closing price of $0.26.
This summary was machine generated May 5 at 12:08 GMT. All
figures in US dollars unless otherwise stated